RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 56 filers reported holding RECRO PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $29,000 | +107.1% | 18,000 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $14,000 | -56.2% | 18,000 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $32,000 | +45.5% | 18,000 | +38.5% | 0.00% | 0.0% |
Q4 2021 | $22,000 | -18.5% | 13,000 | 0.0% | 0.00% | +50.0% |
Q3 2021 | $27,000 | -10.0% | 13,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $30,000 | – | 13,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |